396 related articles for article (PubMed ID: 32901590)
1. Role of Inflammation in the Development of Colorectal Cancer.
Muthusami S; Ramachandran IK; Babu KN; Krishnamoorthy S; Guruswamy A; Queimado L; Chaudhuri G; Ramachandran I
Endocr Metab Immune Disord Drug Targets; 2021; 21(1):77-90. PubMed ID: 32901590
[TBL] [Abstract][Full Text] [Related]
2. Regulation of MicroRNAs in Inflammation-Associated Colorectal Cancer: A Mechanistic Approach.
Muthusami S; Ramachandran I; Krishnamoorthy S; Sambandam Y; Ramalingam S; Queimado L; Chaudhuri G; Ramachandran IK
Endocr Metab Immune Disord Drug Targets; 2021; 21(1):67-76. PubMed ID: 32940190
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory natural product goniothalamin reduces colitis-associated and sporadic colorectal tumorigenesis.
Vendramini-Costa DB; Francescone R; Posocco D; Hou V; Dmitrieva O; Hensley H; de Carvalho JE; Pilli RA; Grivennikov SI
Carcinogenesis; 2017 Jan; 38(1):51-63. PubMed ID: 27797827
[TBL] [Abstract][Full Text] [Related]
4. Inflammation and colorectal cancer.
Kraus S; Arber N
Curr Opin Pharmacol; 2009 Aug; 9(4):405-10. PubMed ID: 19589728
[TBL] [Abstract][Full Text] [Related]
5. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
Pedersen G
Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
[TBL] [Abstract][Full Text] [Related]
6. Intestinal inflammation and colorectal cancer: a double-edged sword?
Rizzo A; Pallone F; Monteleone G; Fantini MC
World J Gastroenterol; 2011 Jul; 17(26):3092-100. PubMed ID: 21912451
[TBL] [Abstract][Full Text] [Related]
7. Inactivation of JNK2 as carcinogenic factor in colitis-associated and sporadic colorectal carcinogenesis.
Lessel W; Silver A; Jechorek D; Guenther T; Roehl FW; Kalinski T; Roessner A; Poehlmann-Nitsche A
Carcinogenesis; 2017 May; 38(5):559-569. PubMed ID: 28383667
[TBL] [Abstract][Full Text] [Related]
8. Investigating intestinal inflammation in DSS-induced model of IBD.
Kim JJ; Shajib MS; Manocha MM; Khan WI
J Vis Exp; 2012 Feb; (60):. PubMed ID: 22331082
[TBL] [Abstract][Full Text] [Related]
9. Study of tumor necrosis factor receptor in the inflammatory bowel disease.
Souza RF; Caetano MAF; Magalhães HIR; Castelucci P
World J Gastroenterol; 2023 May; 29(18):2733-2746. PubMed ID: 37274062
[TBL] [Abstract][Full Text] [Related]
10. A novel mouse model of inflammatory bowel disease links mammalian target of rapamycin-dependent hyperproliferation of colonic epithelium to inflammation-associated tumorigenesis.
Deng L; Zhou JF; Sellers RS; Li JF; Nguyen AV; Wang Y; Orlofsky A; Liu Q; Hume DA; Pollard JW; Augenlicht L; Lin EY
Am J Pathol; 2010 Feb; 176(2):952-67. PubMed ID: 20042677
[TBL] [Abstract][Full Text] [Related]
11. Pro-inflammatory TNF-α and IFN-γ Promote Tumor Growth and Metastasis via Induction of MACC1.
Kobelt D; Zhang C; Clayton-Lucey IA; Glauben R; Voss C; Siegmund B; Stein U
Front Immunol; 2020; 11():980. PubMed ID: 32670264
[TBL] [Abstract][Full Text] [Related]
12. Overview of molecular pathways in inflammatory bowel disease associated with colorectal cancer development.
Azer SA
Eur J Gastroenterol Hepatol; 2013 Mar; 25(3):271-81. PubMed ID: 23169309
[TBL] [Abstract][Full Text] [Related]
13. KFL2 participates in the development of ulcerative colitis through inhibiting inflammation via regulating cytokines.
Wang ZL; Wang YD; Wang K; Li JA; Li L
Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4941-4948. PubMed ID: 30070340
[TBL] [Abstract][Full Text] [Related]
14. Potential dual immunomodulatory role of VEGF in ulcerative colitis and colorectal carcinoma.
Zdravkovic ND; Jovanovic IP; Radosavljevic GD; Arsenijevic AN; Zdravkovic ND; Mitrovic SLj; Arsenijevic NN
Int J Med Sci; 2014; 11(9):936-47. PubMed ID: 25076849
[TBL] [Abstract][Full Text] [Related]
15. Cytokines: from gut inflammation to colorectal cancer.
Fantini MC; Pallone F
Curr Drug Targets; 2008 May; 9(5):375-80. PubMed ID: 18473765
[TBL] [Abstract][Full Text] [Related]
16. Cytokines in colitis associated cancer: potential drug targets?
Waldner MJ; Neurath MF
Inflamm Allergy Drug Targets; 2008 Sep; 7(3):187-94. PubMed ID: 18782026
[TBL] [Abstract][Full Text] [Related]
17. Retinoid acid induced 16 deficiency aggravates colitis and colitis-associated tumorigenesis in mice.
Xu YL; Ding CL; Qian CL; Qi ZT; Wang W
Cell Death Dis; 2019 Dec; 10(12):958. PubMed ID: 31862898
[TBL] [Abstract][Full Text] [Related]
18. Novel Biomarkers for Inflammatory Bowel Disease and Colorectal Cancer: An Interplay between Metabolic Dysregulation and Excessive Inflammation.
Salla M; Guo J; Joshi H; Gordon M; Dooky H; Lai J; Capicio S; Armstrong H; Valcheva R; Dyck JRB; Thiesen A; Wine E; Dieleman LA; Baksh S
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36983040
[TBL] [Abstract][Full Text] [Related]
19. Intestinal immunomodulation. Role of regulative peptides and promising pharmacological activities.
Motilva V; Talero E; Calvo JR; Villegas I; Alarcón-de-la-Lastra C; Sánchez-Fidalgo S
Curr Pharm Des; 2008; 14(1):71-95. PubMed ID: 18220820
[TBL] [Abstract][Full Text] [Related]
20. Impact of COX-2, IL-1β, TNF-α, IL-4 and IL-10 on the process of carcinogenesis in the large bowel.
Marszałek A; Szylberg L; Wiśniewska E; Janiczek M
Pol J Pathol; 2012 Dec; 63(4):221-7. PubMed ID: 23359190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
